Martha Shadan - 04 Jun 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Jun 2026, 17:35:06 UTC
Prior SEC filing
03 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

Martha Shadan filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 05 Jun 2026.

Key facts

  • This page summarizes Martha Shadan's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
  • 5 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 05 Jun 2026, 17:35.

Change

  • Previous filing in this sequence was filed on 03 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001871700 Primary reporting owner

SHADAN MARTHA

Relationship
Director
Address
C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Signature date
05 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares
+0
Change %
+10%
Price
$0.000000*
Shares after
5
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
0
Exercise price
Footnotes
F1
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares
+1
Change %
+13%
Price
$0.000000*
Shares after
5
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1
Exercise price
Footnotes
F2
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares
+1
Change %
+21%
Price
$0.000000*
Shares after
4
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1
Exercise price
Footnotes
F3
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares
+1
Change %
+24%
Price
$0.000000*
Shares after
4
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1
Exercise price
Footnotes
F4
LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares
+1
Change %
+118%
Price
$0.000000*
Shares after
3
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1
Exercise price
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F2

These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F3

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F4

These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F5

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .